(Q37203934)

18 August 2017

1 reference

title

The exploration of macrocycles for drug discovery--an underexploited structural class (English)

1 reference

18 August 2017

1 reference

Edward M Driggers

1

1 reference

18 August 2017

Stephen P Hale

series ordinal

2

1 reference

18 August 2017

Jinbo Lee

series ordinal

3

1 reference

18 August 2017

Nicholas K Terrett

series ordinal

4

1 reference

18 August 2017

publication date

1 July 2008

1 reference

Nature Reviews Drug Discovery

18 August 2017

published in

1 reference

18 August 2017

volume

7

1 reference

18 August 2017

issue

7

1 reference

18 August 2017

page(s)

608-624

1 reference

From protein domains to drug candidates-natural products as guiding principles in the design and synthesis of compound libraries

18 August 2017

cites work

1 reference

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

31 March 2020

1 reference

What can a chemist learn from nature's macrocycles?--a brief, conceptual view.

31 March 2020

1 reference

Why are secondary metabolites (natural products) biosynthesized?

31 March 2020

1 reference

On the evolution of functional secondary metabolites (natural products)

31 March 2020

1 reference

Discovery of cyclotide-like protein sequences in graminaceous crop plants: ancestral precursors of circular proteins?

31 March 2020

1 reference

A common protein fold topology shared by flavonoid biosynthetic enzymes and therapeutic targets.

31 March 2020

1 reference

The evolution and role of macrolides in infectious diseases

31 March 2020

1 reference

Combinatorial synthesis of natural products.

31 March 2020

1 reference

Synthesis of natural-product-based compound libraries

31 March 2020

1 reference

Species-specific secondary metabolite production in marine actinomycetes of the genus Salinispora

31 March 2020

1 reference

Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica

31 March 2020

1 reference

Evolutionary implications of bacterial polyketide synthases

31 March 2020

1 reference

Discovery of a new source of rifamycin antibiotics in marine sponge actinobacteria by phylogenetic prediction

31 March 2020

1 reference

Natural products as sources of new drugs over the period 1981-2002.

31 March 2020

1 reference

Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP

31 March 2020

1 reference

Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis

31 March 2020

1 reference

Natural products to drugs: natural product derived compounds in clinical trials

31 March 2020

1 reference

Current development of mTOR inhibitors as anticancer agents

31 March 2020

1 reference

Immunophilin-sensitive protein phosphatase action in cell signaling pathways

31 March 2020

1 reference

The mechanism of action of cyclosporin A and FK506

31 March 2020

1 reference

Epothilones as lead structures for the synthesis-based discovery of new chemotypes for microtubule stabilization

31 March 2020

1 reference

Structure of tubulin at 6.5 A and location of the taxol-binding site.

31 March 2020

1 reference

Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin.

31 March 2020

1 reference

Synergistic effects of peloruside A and laulimalide with taxoid site drugs, but not with each other, on tubulin assembly.

31 March 2020

1 reference

Comparison of the activities of the truncated halichondrin B analog NSC 707389 (E7389) with those of the parent compound and a proposed binding site on tubulin.

31 March 2020

1 reference

Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria

31 March 2020

1 reference

The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome

31 March 2020

1 reference

Inhibitors of serine proteases as potential therapeutic agents: the road from thrombin to tryptase to cathepsin G.

31 March 2020

1 reference

Resisting degradation by human elastase: commonality of design features shared by 'canonical' plant and bacterial macrocyclic protease inhibitor scaffolds

31 March 2020

1 reference

Amphotericin B covalent dimers forming sterol-dependent ion-permeable membrane channels

31 March 2020

1 reference

The design, computer modeling, solution structure, and biological evaluation of synthetic analogs of bryostatin 1.

31 March 2020

1 reference

The evolving role of natural products in drug discovery

31 March 2020

1 reference

Rapamycin analogs with differential binding specificity permit orthogonal control of protein activity

31 March 2020

1 reference

Antascomicins A, B, C, D and E. Novel FKBP12 binding compounds from a Micromonospora strain

31 March 2020

1 reference

Solid- and solution-phase synthesis of vancomycin and vancomycin analogues with activity against vancomycin-resistant bacteria

31 March 2020

1 reference

Synthesis and biological evaluation of vancomycin dimers with potent activity against vancomycin-resistant bacteria: target-accelerated combinatorial synthesis.

31 March 2020

1 reference

Mechanism of action of oritavancin and related glycopeptide antibiotics

31 March 2020

1 reference

Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease

31 March 2020

1 reference

Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection

31 March 2020

1 reference

Structure-activity study on a novel series of macrocyclic inhibitors of the hepatitis C virus NS3 protease leading to the discovery of BILN 2061.

31 March 2020

1 reference

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

31 March 2020

1 reference

Relationship of stereochemical and skeletal diversity of small molecules to cellular measurement space

31 March 2020

1 reference

(S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta

31 March 2020

1 reference

Comparison of the ATP binding sites of protein kinases using conformationally diverse bisindolylmaleimides

31 March 2020

1 reference

Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers.

31 March 2020

1 reference

Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides

31 March 2020

1 reference

Macrocyclic inhibitors of beta-secretase: functional activity in an animal model

31 March 2020

1 reference

Peptidomimetics derived from natural products

31 March 2020

1 reference

Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles

31 March 2020

1 reference

3-Aminopyrrolidinone farnesyltransferase inhibitors: design of macrocyclic compounds with improved pharmacokinetics and excellent cell potency

31 March 2020

1 reference

Conformationally constrained macrocycles that mimic tripeptide beta-strands in water and aprotic solvents

31 March 2020

1 reference

Macrocyclization by Ring-Closing Metathesis in the Total Synthesis of Natural Products: Reaction Conditions and Limitations

31 March 2020

1 reference

Macrocycles rapidly produced by multiple multicomponent reactions including bifunctional building blocks (MiBs).

31 March 2020

1 reference

Difficult Macrocyclizations: New Strategies for Synthesizing Highly Strained Cyclic Tetrapeptides

31 March 2020

1 reference

Intramolecular Staudinger ligation: a powerful ring-closure method to form medium-sized lactams

31 March 2020

1 reference

Macrolactones in diversity-oriented synthesis: preparation of a pilot library and exploration of factors controlling macrocyclization

31 March 2020

1 reference

Discovery of a new class of macrocyclic antagonists to the human motilin receptor.

31 March 2020

1 reference

DNA-templated organic synthesis and selection of a library of macrocycles

31 March 2020

1 reference

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics

31 March 2020

1 reference

Phylogenetic analysis of the genera Streptomyces and Kitasatospora based on partial RNA polymerase beta-subunit gene (rpoB) sequences

31 March 2020

1 reference

Conformational restriction of flexible ligands guided by the transferred noe experiment: potent macrocyclic inhibitors of farnesyltransferase

31 March 2020

1 reference

Bridged peptide macrocycles as ligands for PDZ domain proteins

31 March 2020

1 reference

Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitors.

31 March 2020

1 reference

A novel macrocyclic tetrapeptide mimetic that exhibits low-picomolar Grb2 SH2 domain-binding affinity

31 March 2020

1 reference

Development of a phosphatase-stable phosphotyrosyl mimetic suitably protected for the synthesis of high-affinity Grb2 SH2 domain-binding ligands

31 March 2020

1 reference

Novel bis(indolyl)maleimide pyridinophanes that are potent, selective inhibitors of glycogen synthase kinase-3

31 March 2020

1 reference

Structure-based drug design of a highly potent CDK1,2,4,6 inhibitor with novel macrocyclic quinoxalin-2-one structure

31 March 2020

1 reference

Macrocyclic aminopyrimidines as multitarget CDK and VEGF-R inhibitors with potent antiproliferative activities

31 March 2020

1 reference

Exploiting ligand conformation in selective inhibition of non-ribosomal peptide synthetase amino acid adenylation with designed macrocyclic small molecules

31 March 2020

1 reference

Macrocyclic amino carboxylates as selective MMP-8 inhibitors

31 March 2020

1 reference

Structure-based design of a macrocyclic inhibitor for peptide deformylase

31 March 2020

1 reference

Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size

31 March 2020

1 reference

Renin inhibitors containing conformationally restricted P1-P1' dipeptide mimetics

31 March 2020

1 reference

Design and synthesis of P2-P1'-linked macrocyclic human renin inhibitors

31 March 2020

1 reference

Highly potent, orally active diester macrocyclic human renin inhibitors

31 March 2020

1 reference

Synthesis, stability, antiviral activity, and protease-bound structures of substrate-mimicking constrained macrocyclic inhibitors of HIV-1 protease

31 March 2020

1 reference

Countering cooperative effects in protease inhibitors using constrained beta-strand-mimicking templates in focused combinatorial libraries

31 March 2020

1 reference

Design, synthesis, and conformational analysis of a novel macrocyclic HIV-protease inhibitor

31 March 2020

1 reference

Potent macrocyclic antagonists to the motilin receptor presenting novel unnatural amino acids.

31 March 2020

1 reference

High-throughput synthesis and screening of cyclic peptide antibiotics

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRD2590

1 reference

18 August 2017

1 reference